Sullivan & Cromwell LLP Logo
  • Home
  • Lawyers
  • Practices
  • Insights
  • About
  • Careers
  • Alumni
  • Twitter icon
  • LinkedIn icon
  •  icon
  • Podcasts icon
© 2025 Sullivan & Cromwell LLP
    • Home
    • Lawyers
    • Practices
    • Insights
    • About
    • Careers
    • Alumni
    Home /  About /  Rankings And Recognitions /  Firm Highlights
    Firm Highlights

    S&C Advises Amgen in the Largest Healthcare Merger of 2022

    • Our Lawyers
    • Related Practices
    December 16, 2022

    In the largest healthcare merger announced this year, S&C is advising biotechnology company Amgen in its pending acquisition of Horizon Therapeutics for an enterprise value of $28.3 billion, with the client prevailing over competing bids. Horizon Therapeutics is a global biotechnology company headquartered in Dublin, Ireland that develops medicines that address critical needs for people affected by rare, autoimmune and severe inflammatory diseases.

    The cross-border S&C team advising Amgen includes Frank Aquila, Miaoting (Mimi) Wu, Spencer Nord and Andrew Kim. The finance team, which helped secure $28.5 billion in acquisition financing, included Ari Blaut, Presley Warner, Joyce Kwok, Matthew Squire, Hannah Cockle and Dermot Costello. Heather Coleman and Rebecca Rabinowitz are advising on executive compensation. Davis Wang, HyunKyu Kim and Stephen Profeta are advising on tax matters. Nader A. Mousavi, RuiHui (Rachel) Yu, KJ Lim, Jamie Chang, Elizabeth Levin and Elianne Neuman Schiff are advising on intellectual property matters. Renata Hesse, Michael Rosenthal, Alexander Minore, Matt Bogdan and Marielena Doeding are advising on competition matters.

    S&C has counseled the biotechnology company for nearly two decades, including advising on Amgen’s $1.9 billion acquisition of Five Prime Therapeutics in 2021, its $13.4 billion purchase of the worldwide rights to Otezla in 2019, its $9.7 billion acquisition of Onyx Pharmaceuticals in 2013 and its $2.2 billion purchase of Abgenix in 2005.

    Our multidisciplinary Healthcare & Life Sciences practice delivers best-in-class services to clients of all sizes, from start-ups to investment funds to the largest global healthcare businesses. We have advised on some of the largest recent deals in this sphere, including Abiomed’s $18 billion pending acquisition by J&J, Biohaven Pharmaceuticals’ $11.6 billion acquisition by Pfizer, Baxter International’s $12.4 billion acquisition of Hillrom, and Haleon’s demerger from GSK and landmark European listing creating the world's biggest stand-alone consumer health company.

    Recent Podcasts and Videos

    • Keith Pagnani Discusses Medtech M&A Trends on “Capital Forum”
    • S&C Critical Insights – Impact of Illumina/GRAIL on M&A Deals Going Forward
    Read More
    Stay Updated

    Subscribe to stay current on S&C Insights.

    Our Lawyers

    Our Lawyers

    Francis J. Aquila Headshot Photo
    Francis J. Aquila
    New York
    +1-212-558-4048
    Email
    vCard
    Miaoting (Mimi) Wu Headshot Photo
    Miaoting (Mimi) Wu
    New York
    +1-212-558-4000
    Email
    vCard
    Ben Perry Headshot Photo
    Ben Perry
    London
    +44-20-7959-8900
    Email
    vCard
    Ari B. Blaut Headshot Photo
    Ari B. Blaut
    New York
    +1-212-558-1656
    Email
    vCard
    Joyce Y. Kwok Headshot Photo
    Joyce Y. Kwok
    New York
    +1-212-558-4000
    Email
    vCard
    Heather L. Coleman Headshot Photo
    Heather L. Coleman
    New York
    +1-212-558-4000
    Email
    vCard
    Davis J. Wang Headshot Photo
    Davis J. Wang
    New York
    +1-212-558-4000
    Email
    vCard
    Nader A. Mousavi Headshot Photo
    Nader A. Mousavi
    Palo Alto
    +1-650-461-5600
    Email
    vCard
    RuiHui (Rachel) Yu Headshot Photo
    RuiHui (Rachel) Yu
    New York
    +1-212-558-4000
    Email
    vCard
    Renata B. Hesse Headshot Photo
    Renata B. Hesse
    Washington, D.C.
    +1-202-956-7500
    Email
    vCard
    Read More

    Related Practices

    • Credit & Leveraged Finance
    • Executive Compensation
    • Healthcare & Life Sciences
    • Intellectual Property & Technology Transactions
    • Mergers & Acquisitions
    • Tax
    Sullivan & Cromwell LLP Logo
    • Twitter icon
    • LinkedIn icon
    • RSS Feed icon
    • Podcasts icon
    • Home
    • Contact Us
    • Information Policy Relating to Cookies
    • Privacy Policy
    • California Privacy Policy
    • Website Notice
    • Attorney Advertising Notice
    © 2025 Sullivan & Cromwell LLP